Banka, Puja

ACC/AHA/ASE/HRS/ISACHD/SCAI/SCCT/SCMR/SOPE 2020 Appropriate Use Criteria for Multimodality Imaging During the Follow-Up Care of Patients With Congenital Heart Disease

Sachdeva, R., Valente, A. M., Armstrong, A. K., Cook, S. C., Han, B. K., Lopez, L., Lui, G. K., Pickard, S. S., Powell, A. J., Bhave, N. M., et al. (2020) · Journal of the American College of Cardiology

Congenital Heart Disease StudiesCardiac Imaging and Diagnostics

Cited by 193

Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial

Ballantyne, C. M., Gellis, L., Tardif, J.-C., Banka, P., Navar, A. M., Asprusten, E. A., Scott, R., Stroes, E. S. G., Froman, S., Mendizabal, G., et al. (2026) · JAMA

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 68

A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide

Navar, A. M., Mikhailova, E., Catapano, A. L., Banka, P., Blom, D. J., Cadena, A., Kourpanidis, S., Lepor, N. E., Tsukamoto, K., Mendizabal, G., et al. (2026) · New England Journal of Medicine

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 57

Oral PCSK9 Inhibitor Enlicitide Versus Oral Nonstatin Therapies

Catapano, A. L., Mikhailova, E., Navar, A. M., Banka, P., Corral, P., Saxena, M., Steg, P. G., Verma, S., Kordahi, A. Y., Mendizabal, G., et al. (2026) · JACC

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 19

Transcatheter balloon dilation for recurrent right ventricular outflow tract obstruction following valve‐sparing repair of tetralogy of Fallot

Gellis, L., Banka, P., Marshall, A., Emani, S., & Porras, D. (2015) · Catheterization and Cardiovascular Interventions

Congenital Heart Disease StudiesCardiac Valve Diseases and Treatments

Cited by 13